Suppr超能文献

磷酸盐对于环孢素 A 或亲环蛋白 D 缺失对线粒体通透性转换的抑制作用不是必需的。

Phosphate is not an absolute requirement for the inhibitory effects of cyclosporin A or cyclophilin D deletion on mitochondrial permeability transition.

机构信息

Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA.

出版信息

Biochem J. 2012 Apr 1;443(1):185-91. doi: 10.1042/BJ20111881.

Abstract

CypD (cyclophilin D) has been established as a critical regulator of the MPT (mitochondrial permeability transition) pore, and pharmacological or genetic inhibition of CypD attenuates MPT in numerous systems. However, it has recently been suggested that the inhibitory effects of CypD inhibition only manifest when P(i) (inorganic phosphate) is present, and that inhibition is lost when P(i) is replaced by As(i) (inorganic arsenate) or V(i) (inorganic vanadate). To test this, liver mitochondria were isolated from wild-type and CypD-deficient (Ppif-/-) mice and then incubated in buffer containing P(i), As(i) or V(i). MPT was induced under both energized and de-energized conditions by the addition of Ca2+, and the resultant mitochondrial swelling was measured spectrophotometrically. For pharmacological inhibition of CypD, wild-type mitochondria were pre-incubated with CsA (cyclosporin A) before the addition of Ca2+. In energized and de-energized mitochondria, Ca2+ induced MPT regardless of the anion present, although the magnitude differed between P(i), As(i) and V(i). However, in all cases, pre-treatment with CsA significantly inhibited MPT. Moreover, these effects were independent of mouse strain, organ type and rodent species. Similarly, attenuation of Ca2+-induced MPT in the Ppif-/- mitochondria was still observed irrespective of whether P(i), As(i) or V(i) was present. We conclude that the pharmacological and genetic inhibition of CypD is still able to attenuate MPT even in the absence of P(i).

摘要

CypD(亲环素 D)已被确定为 MPT(线粒体通透性转换)孔的关键调节因子,药理学或遗传学抑制 CypD 可减轻许多系统中的 MPT。然而,最近有人提出,CypD 抑制的抑制作用仅在存在 P(i)(无机磷酸盐)时才表现出来,并且当 P(i)被 As(i)(无机砷酸盐)或 V(i)(无机钒酸盐)取代时,抑制作用就会丧失。为了验证这一点,从野生型和 CypD 缺陷型(Ppif-/-)小鼠中分离出线粒体,然后在含有 P(i)、As(i)或 V(i)的缓冲液中孵育。通过添加 Ca2+,在有能量和无能量的条件下诱导 MPT,然后通过分光光度法测量线粒体肿胀。对于 CypD 的药理学抑制,在添加 Ca2+之前,用 CsA(环孢菌素 A)预孵育野生型线粒体。在有能量和无能量的线粒体中,Ca2+诱导 MPT 与存在的阴离子无关,尽管 P(i)、As(i)和 V(i)之间的大小有所不同。然而,在所有情况下,CsA 的预处理都显著抑制了 MPT。此外,这些影响与小鼠品系、器官类型和啮齿动物种类无关。同样,在无论是否存在 P(i)、As(i)或 V(i)的情况下,仍观察到 Ppif-/- 线粒体中 Ca2+诱导的 MPT 减弱。我们得出结论,即使在没有 P(i)的情况下,CypD 的药理学和遗传学抑制仍然能够减轻 MPT。

相似文献

9
Estrogen receptor beta modulates permeability transition in brain mitochondria.雌激素受体β调节脑线粒体的通透性转换。
Biochim Biophys Acta Bioenerg. 2018 Jun;1859(6):423-433. doi: 10.1016/j.bbabio.2018.03.006. Epub 2018 Mar 14.

引用本文的文献

3
Regulated cell death in cisplatin-induced AKI: relevance of -inositol metabolism.顺铂诱导 AKI 中的细胞程序性死亡:肌醇代谢的相关性。
Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F578-F595. doi: 10.1152/ajprenal.00016.2021. Epub 2021 Feb 22.
7
Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.线粒体靶向肽苯达维减轻早期再灌注损伤
J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):121-32. doi: 10.1177/1074248413508003. Epub 2013 Nov 28.

本文引用的文献

7
Mitochondrial calcium and the permeability transition in cell death.线粒体钙与细胞死亡中的通透性转换
Biochim Biophys Acta. 2009 Nov;1787(11):1395-401. doi: 10.1016/j.bbabio.2009.06.009. Epub 2009 Jul 1.
8
Cyclophilin D gene ablation protects mice from ischemic renal injury.亲环素D基因敲除可保护小鼠免受缺血性肾损伤。
Am J Physiol Renal Physiol. 2009 Sep;297(3):F749-59. doi: 10.1152/ajprenal.00239.2009. Epub 2009 Jun 24.
10
Regulation and pharmacology of the mitochondrial permeability transition pore.线粒体通透性转换孔的调控与药理学
Cardiovasc Res. 2009 Jul 15;83(2):213-25. doi: 10.1093/cvr/cvp151. Epub 2009 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验